Macrogenics (MGNX)

$1.67 -0.04 (-2.34%)
Market Cap 107.88M
Revenue (ttm) 149.96M
Net Income (ttm) -66.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -44.66%
Debt to Equity Ratio 0.00
Volume 524,757
Avg Vol 1,403,210
Day's Range N/A - N/A
Shares Out 63.09M
Stochastic %K 59%
Beta 1.59
Analysts Sell
Price Target $4.20

Company Profile

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which ha...

Industry: Biotechnology
Sector: Healthcare
Phone: 301 251 5172
Fax: 301 251 5321
Address:
9704 Medical Center Drive, Rockville, United States
waterlock
waterlock Jul. 28 at 2:11 AM
$MGNX what are the remaining milestones this year?
0 · Reply
redistributeW
redistributeW Jul. 27 at 9:39 PM
$MGNX In the last 12 months, this company has received from Incyte 100 million Sagard 70 million TerSera 40 million
0 · Reply
CandleOps
CandleOps Jul. 23 at 7:43 PM
$MGNX done now hehe 25% up
1 · Reply
PSDL75
PSDL75 Jul. 23 at 7:40 PM
$MGNX Not a lot of commenting, but if you remember the announcement push PM that got sold was unable to break out, but this move today looks encouraging. To be sure, let's watch out for MM to slam this into the cloud out close.
0 · Reply
MarketWarfare
MarketWarfare Jul. 23 at 7:19 PM
$MGNX most undervalued biotech in existence. Been artificially held down for a year and now is ready to explode.
1 · Reply
PSDL75
PSDL75 Jul. 23 at 7:19 PM
$MGNX Too early?
0 · Reply
CandleOps
CandleOps Jul. 23 at 2:42 PM
$MGNX got my 15% since this . Outta here
1 · Reply
MarketWarfare
MarketWarfare Jul. 23 at 2:27 PM
$MGNX nice run today, but who is selling into every pop and keeping this stock from ever really running? Ask size is loaded.
0 · Reply
SkyLonger
SkyLonger Jul. 23 at 1:19 PM
$MGNX nice!!
0 · Reply
CandleOps
CandleOps Jul. 22 at 7:54 PM
$MGNX has been issued a patent related to their lead drug today titled 'PHARMACEUTICAL COMPOSITIONS OF A PD-1 ANTIBODY AND USE OF THE SAME '
2 · Reply
Latest News on MGNX
MacroGenics: Working On That Road To Recovery

Jun 11, 2025, 6:32 PM EDT - 6 weeks ago

MacroGenics: Working On That Road To Recovery

MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement

Jun 10, 2025, 7:00 AM EDT - 6 weeks ago

MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement

MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Jun 3, 2025, 4:30 PM EDT - 7 weeks ago

MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results

May 13, 2025, 4:01 PM EDT - 2 months ago

MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results

MacroGenics Announces Date of First Quarter 2025 Financial Results

May 6, 2025, 4:30 PM EDT - 2 months ago

MacroGenics Announces Date of First Quarter 2025 Financial Results

MacroGenics to Participate in Upcoming Investor Conference

May 1, 2025, 4:30 PM EDT - 3 months ago

MacroGenics to Participate in Upcoming Investor Conference

MacroGenics, Inc. (MGNX) Q4 2024 Earnings Call Transcript

Mar 20, 2025, 7:09 PM EDT - 4 months ago

MacroGenics, Inc. (MGNX) Q4 2024 Earnings Call Transcript

MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call

Mar 6, 2025, 7:30 AM EST - 5 months ago

MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call

MacroGenics: Stacking Up A Lot Of Headwinds

Feb 27, 2025, 2:08 PM EST - 5 months ago

MacroGenics: Stacking Up A Lot Of Headwinds

MacroGenics to Participate in Upcoming Investor Conferences

Feb 27, 2025, 7:30 AM EST - 5 months ago

MacroGenics to Participate in Upcoming Investor Conferences

MacroGenics, Inc. (MGNX) Q2 2024 Earnings Call Transcript

Nov 5, 2024, 7:01 PM EST - 9 months ago

MacroGenics, Inc. (MGNX) Q2 2024 Earnings Call Transcript

MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results

Nov 5, 2024, 4:01 PM EST - 9 months ago

MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results

MacroGenics Announces Leadership Transition

Oct 30, 2024, 7:30 AM EDT - 9 months ago

MacroGenics Announces Leadership Transition

MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call

Oct 29, 2024, 4:30 PM EDT - 9 months ago

MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call

Rigrodsky Law, P.A. Is Investigating MacroGenics, Inc. On Behalf of Shareholders

Oct 25, 2024, 5:15 PM EDT - 9 months ago

Rigrodsky Law, P.A. Is Investigating MacroGenics, Inc. On Behalf of Shareholders

MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®

Oct 22, 2024, 7:30 AM EDT - 9 months ago

MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®

Shareholders of MacroGenics, Inc. Should Contact The Gross Law Firm Before September 24, 2024 to Discuss Your Rights – MGNX

Sep 24, 2024, 12:57 PM EDT - 10 months ago

Shareholders of MacroGenics, Inc. Should Contact The Gross Law Firm Before September 24, 2024 to Discuss Your Rights – MGNX

MGNX Investors Have Opportunity to Join MacroGenics, Inc. Fraud Investigation with the Schall Law Firm

Sep 24, 2024, 10:30 AM EDT - 10 months ago

MGNX Investors Have Opportunity to Join MacroGenics, Inc. Fraud Investigation with the Schall Law Firm

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Encouraged To Contact The Schall Law Firm

Sep 23, 2024, 11:00 AM EDT - 11 months ago

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Encouraged To Contact The Schall Law Firm

MacroGenics (MGNX) Accused of Misleading Investors Over Cancer Drug Trial - Hagens Berman

Sep 22, 2024, 11:09 AM EDT - 11 months ago

MacroGenics (MGNX) Accused of Misleading Investors Over Cancer Drug Trial - Hagens Berman

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Reach Out To The Schall Law Firm

Sep 21, 2024, 11:00 AM EDT - 11 months ago

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Reach Out To The Schall Law Firm

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders Are Urged To Contact The Schall Law Firm

Sep 19, 2024, 11:00 AM EDT - 11 months ago

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders Are Urged To Contact The Schall Law Firm

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics

Sep 19, 2024, 9:57 AM EDT - 11 months ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics Lawsuit - MGNX

Sep 19, 2024, 5:45 AM EDT - 11 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics Lawsuit - MGNX

MGNX Deadline: Rosen Law Firm Urges MacroGenics, Inc. (NASDAQ: MGNX) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Sep 17, 2024, 11:23 AM EDT - 11 months ago

MGNX Deadline: Rosen Law Firm Urges MacroGenics, Inc. (NASDAQ: MGNX) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Hospice Dynamix Welcomes Industry Veteran Rob Stoltz as Chief Strategy Officer

Sep 17, 2024, 11:04 AM EDT - 11 months ago

Hospice Dynamix Welcomes Industry Veteran Rob Stoltz as Chief Strategy Officer

MacroGenics Inc May Have Violated Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm About A Suit

Sep 17, 2024, 11:00 AM EDT - 11 months ago

MacroGenics Inc May Have Violated Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm About A Suit

Investor Reminder (MGNX):  Kessler Topaz Meltzer & Check, LLP Reminds MacroGenics, Inc.  Investors of September 24, 2024 Deadline

Sep 16, 2024, 12:14 PM EDT - 11 months ago

Investor Reminder (MGNX):  Kessler Topaz Meltzer & Check, LLP Reminds MacroGenics, Inc.  Investors of September 24, 2024 Deadline

MacroGenics Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Contact The Schall Law Firm

Sep 15, 2024, 11:00 AM EDT - 11 months ago

MacroGenics Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Contact The Schall Law Firm

MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024

Sep 15, 2024, 3:00 AM EDT - 11 months ago

MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024

waterlock
waterlock Jul. 28 at 2:11 AM
$MGNX what are the remaining milestones this year?
0 · Reply
redistributeW
redistributeW Jul. 27 at 9:39 PM
$MGNX In the last 12 months, this company has received from Incyte 100 million Sagard 70 million TerSera 40 million
0 · Reply
CandleOps
CandleOps Jul. 23 at 7:43 PM
$MGNX done now hehe 25% up
1 · Reply
PSDL75
PSDL75 Jul. 23 at 7:40 PM
$MGNX Not a lot of commenting, but if you remember the announcement push PM that got sold was unable to break out, but this move today looks encouraging. To be sure, let's watch out for MM to slam this into the cloud out close.
0 · Reply
MarketWarfare
MarketWarfare Jul. 23 at 7:19 PM
$MGNX most undervalued biotech in existence. Been artificially held down for a year and now is ready to explode.
1 · Reply
PSDL75
PSDL75 Jul. 23 at 7:19 PM
$MGNX Too early?
0 · Reply
CandleOps
CandleOps Jul. 23 at 2:42 PM
$MGNX got my 15% since this . Outta here
1 · Reply
MarketWarfare
MarketWarfare Jul. 23 at 2:27 PM
$MGNX nice run today, but who is selling into every pop and keeping this stock from ever really running? Ask size is loaded.
0 · Reply
SkyLonger
SkyLonger Jul. 23 at 1:19 PM
$MGNX nice!!
0 · Reply
CandleOps
CandleOps Jul. 22 at 7:54 PM
$MGNX has been issued a patent related to their lead drug today titled 'PHARMACEUTICAL COMPOSITIONS OF A PD-1 ANTIBODY AND USE OF THE SAME '
2 · Reply
SkyLonger
SkyLonger Jul. 22 at 11:21 AM
$MGNX still, soon enough 🤙
0 · Reply
MarketWarfare
MarketWarfare Jul. 21 at 2:52 PM
$MGNX It is time for worthless POS and loser CEO Scott Koenig to step down. Blackrock sold most of their position because they have no faith in you. Your fired!
0 · Reply
chop14
chop14 Jul. 21 at 10:57 AM
$SRPT do you think $SLDB has better drugs ? $MGNX
0 · Reply
PSDL75
PSDL75 Jul. 16 at 6:37 PM
$MGNX I'm wrecking shop on CRCL and OPEN and have a big stake here doing nothing....trimmed my $PBYI at $3.65 and wondering if it even worth revisiting.
0 · Reply
SkyLonger
SkyLonger Jul. 15 at 10:30 AM
$MGNX Cash run through 1Q of 2027!!! Tell me why this isn't at $3 - $5+ geeeeeezzzzz mm's
0 · Reply
e1908
e1908 Jul. 10 at 3:08 PM
$MGNX all that dip buying paying off
0 · Reply
SkyLonger
SkyLonger Jul. 9 at 10:41 PM
$MGNX still and super....
0 · Reply
never_chase
never_chase Jul. 9 at 8:24 PM
$MGNX loneliness is a good signal here, selling around 5
2 · Reply
Anna_bella
Anna_bella Jul. 8 at 6:56 PM
$MGNX
0 · Reply
SkyLonger
SkyLonger Jul. 8 at 5:59 PM
$MGNX warming up the rocket boosters
0 · Reply
never_chase
never_chase Jul. 8 at 4:46 PM
$MGNX 10% up and nobody posting ?
1 · Reply
MarketWarfare
MarketWarfare Jul. 3 at 2:02 PM
$MGNX grotesquely undervalued at 87M market cap. Downright laughable. Good data within the next 6 months sends this to 10+ and probably a quick acquisition soon thereafter.
0 · Reply